EWOLUTION Risk Model (Watchman Outcomes) Calculator

Clinical calculation support · Verify results before clinical use

Patient risk factors

Enter age and select each comorbidity present before calculating the observed 2-year mortality group.

0Risk factors

Age contributes one risk factor at 76 years or older in the published EWOLUTION grouping.

Enter a whole number from 18 to 120.

—Factors
Observed 2-year all-cause mortality in EWOLUTION
Enter patient details
The registry group estimate will appear here.
Clinical interpretation

This is a group-level registry estimate, not an individualized probability. Use it alongside frailty, competing risks, life expectancy, patient preferences, and current LAAO guidance.

About the EWOLUTION risk model

This risk stratification approach was derived from 1,020 patients in the EWOLUTION real-world registry who underwent percutaneous left atrial appendage occlusion (LAAO). Six independent predictors of 2-year all-cause mortality were combined by counting risk factors: age ≥76 years, heart failure, vascular disease, valvular disease, abnormal liver function, and abnormal renal function.

The reported percentages are observed mortality rates for groups with the same number of factors. They are not calculated from an individualized Cox equation and should not be interpreted as a validated personal risk prediction.

Observed 2-year mortality by risk-factor count

Risk factorsObserved mortality
05.6%
15.7%
214.4%
329.9%
432.5%
5–646.1%

Important limitations

  • The authors did not perform internal or external validation of this risk-factor-count model.
  • Definitions of some comorbidities, including valvular and liver disease, were not fully standardized and could depend on investigator assessment.
  • The cohort reflects patients enrolled in 2013–2015; current devices, workflows, and patient selection may differ.
  • Do not use this estimate alone to deny or recommend LAAO. Consider individual stroke risk, bleeding risk, frailty, competing mortality, expected survival, and shared decision-making.

References

Aarnink EW, Ince H, Kische S, et al. Incidence and predictors of 2-year mortality following percutaneous left atrial appendage occlusion in the EWOLUTION trial. EP Europace. 2024;26(7):euae188. doi:10.1093/europace/euae188. PMID: 39082730.
Clinical disclaimer: This tool summarizes group-level observational data and is not a validated individualized mortality calculator. It does not replace clinical judgment or current professional guidelines. Confirm comorbidity definitions and apply the result in the context of the patient’s overall clinical condition and preferences.